SCHEMBL2993518

SCHEMBL2993518

COC(=O)c1ccc(C(c2ccc(C#Cc3ccccn3)cc2)C(C)(C)C)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 1/20 0.44
KDM4E B2RXH2 3/20 0.43
ALDH1A1 P00352 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2C9 P11712 1/20 0.43
HPGD P15428 1/20 0.43
TSHR P16473 1/20 0.43
CYP2C19 P33261 1/20 0.43
HSD17B10 Q99714 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
MAPT P10636 2/20 0.43
POLB P06746 1/20 0.43
GRM5 P41594 2/20 0.42
PTPN11 Q06124 1/20 0.41
PKM P14618 1/20 0.40
NPC1 O15118 1/20 0.40
NFKB1 P19838 1/20 0.40
RAB9A P51151 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3649040 0.88 FFAR1 (0.53) FFAR1KDM4EALDH1A1TSHRMAPT
SCHEMBL14642565 0.79 TRPV1 (0.50) KDM4EALDH1A1TSHRMAPTPOLB
SCHEMBL12356701 0.77 PARP10 (0.55) KDM4EALDH1A1HPGDMAPTPOLB
SCHEMBL2250280 0.77 PARP10 (0.55) KDM4EALDH1A1HPGDMAPTPOLB
SCHEMBL3000588 0.75 PKM (0.48) KDM4EALDH1A1CYP1A2HPGDMAPT
SCHEMBL25234058 0.74 ALDH1A1 (0.49) ALDH1A1GRM5NPC1RAB9AHAO1
SCHEMBL30563509 0.74 ALDH1A1 (0.49) ALDH1A1GRM5NPC1RAB9AHAO1
SCHEMBL25254448 0.72 GRM5 (0.56) KDM4EMAPTPOLBGRM5NPC1
SCHEMBL30563419 0.72 GRM5 (0.56) KDM4EMAPTPOLBGRM5NPC1
SCHEMBL17213607 0.72 KDM4E (0.50) KDM4EHPGDTSHRMAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2546232-A1 Diphenyl Substituted Alkanes Merck Sharp & Dohme Corp. (US) 2013-01-16 EP disclosed
US-20100190761-A1 DIPHENYL SUBSTITUTED ALKANES MERCK SHARP & DOHME CORP. 2010-07-29 US disclosed
US-20100190761-A1 DIPHENYL SUBSTITUTED ALKANES MERCK SHARP & DOHME CORP. 2010-07-29 US disclosed
EP-2170065-A1 DIPHENYL SUBSTITUTED ALKANES Merck Sharp & Dohme Corp. (US) 2010-04-07 EP disclosed
WO-2008156721-A1 DIPHENYL SUBSTITUTED ALKANES MERCK & CO., INC. (US) 2008-12-24 WO disclosed
WO-2008156721-A1 DIPHENYL SUBSTITUTED ALKANES MERCK & CO., INC. (US) 2008-12-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100190761-A1 DIPHENYL SUBSTITUTED ALKANES ALOX5, ALOX15, ALOX15B FFAR1 73/4885KDM4E 2671/4885ALDH1A1 159/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.